Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.
2.
4.
6.
7.
8.

Low-molecular-weight heparins in the treatment of deep-vein thrombosis.

Martineau P, Tawil N.

Ann Pharmacother. 1998 May;32(5):588-98, 601. Review.

PMID:
9606481
10.

Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.

Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.

Clin Ther. 2007 Nov;29(11):2395-405. Review.

PMID:
18158080
11.

Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.

Holzheimer RG.

Eur J Med Res. 2004 Apr 30;9(4):225-39. Review.

PMID:
15210403
12.

Reviparin sodium - a new low molecular weight heparin.

Breddin HK.

Expert Opin Pharmacother. 2002 Feb;3(2):173-82. Review.

PMID:
11829731
13.
14.

Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.

Belcaro G, Nicolaides AN, Cesarone MR, Laurora G, De Sanctis MT, Incandela L, Barsotti A, Corsi M, Vasdekis S, Christopoulos D, Lennox A, Malouf M.

Angiology. 1999 Oct;50(10):781-7.

PMID:
10535716
15.

Clinical experience with bemiparin.

Abad Rico JI, Lozano Sánchez FS, Rocha E.

Drugs. 2010 Dec 14;70 Suppl 2:25-33. doi: 10.2165/1158584-S0-000000000-00000. Review.

PMID:
21162607
17.

Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis.

Fiessinger JN, Lopez-Fernandez M, Gatterer E, Granqvist S, Kher A, Olsson CG, Söderberg K.

Thromb Haemost. 1996 Aug;76(2):195-9.

PMID:
8865530
18.
19.

Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin).

Mismetti P, Laporte-Simitsidis S, Navarro C, Sié P, d'Azemar P, Necciari J, Duret JP, Gaud C, Decousus H, Boneu B.

Thromb Haemost. 1998 Jun;79(6):1162-5.

PMID:
9657442
20.

Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.

Spyropoulos AC, Turpie AG, Dunn AS, Spandorfer J, Douketis J, Jacobson A, Frost FJ; REGIMEN Investigators.

J Thromb Haemost. 2006 Jun;4(6):1246-52.

PMID:
16706967
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk